The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients

OBJECTIVE: In patients with recurrent ovarian cancer (ROC) in whom surgery is likely to render them disease-free, it is unclear whether secondary cytoreductive surgery (SCS) combined with chemotherapy is superior to chemotherapy alone. The aim of this study was to evaluate the 2 treatment options in...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Makiko, Miyamoto, Taito, Murakami, Ryusuke, Abiko, Kaoru, Hamanishi, Junzo, Baba, Tsukasa, Mandai, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779625/
https://www.ncbi.nlm.nih.gov/pubmed/31576692
http://dx.doi.org/10.3802/jgo.2019.30.e100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779625/
https://www.ncbi.nlm.nih.gov/pubmed/31576692
http://dx.doi.org/10.3802/jgo.2019.30.e100

Ejemplares similares